Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 177 of the 178 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases are incurable and devastating neurological disorders characterized by the progressive loss of the structure and function of neurons in the central nervous system or peripheral nervous system. Mitochondria, organelles found in most eukaryotic cells, are essential for neuronal survival and are involved in a number of neuronal functions. Mitochondrial dysfunction has long been demonstrated as a common prominent early pathological feature of a variety of common neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington’s disease (HD). Mitochondria are highly dynamic organelles that undergo continuous fusion, fission, and transport, the processes of which not only control mitochondrial morphology and number but also regulate mitochondrial function and location. The importance of mitochondrial dynamics in the pathogenesis of neurodegenerative diseases has been increasingly unraveled after the identification of several key fusion and fission regulators such as Drp1, OPA1, and mitofusins. In this review, after a brief discussion of molecular mechanisms regulating mitochondrial fusion, fission, distribution, and trafficking, as well as the important role of mitochondrial dynamics for neuronal function, we review previous and the most recent studies about mitochondrial dynamic abnormalities observed in various major neurodegenerative diseases and discuss the possibility of targeting mitochondrial dynamics as a likely novel therapeutic strategy for neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Therefore, mitochondria and lysosomes appear to have a critical role in the progression of SIPS [239]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [239]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576 · cited 1×
“The prominent pathological hallmark of ALS is the presence of inclusion bodies in degenerating motor neurons, in which TDP-43 has been identified as the major component [130].”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 2×
“Mitochondrial dynamics are very sensitive to physiologic stresses or pathologic stimuli, and mitochondrial dysfunction is a prominent early feature in a wide range of neurological disorders, including cerebral ischemia, stroke, brain trauma, and especially neurodegenerative diseases such as ALS, AD, PD, and HD [8,170,…”
BackgroundChronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · cited 1×
“As one breakthrough in PD research, MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) was found to cause DA neurodegeneration and progressive and levodopa-responsive parkinsonism resembling sporadic PD [105].”
BackgroundParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Boore, J. L. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.8.1767 · Cited by 3,697 · cited 1×
“The mitochondrial genome encodes 13 mRNAs of key subunits of oxidative phosphorylation (OXPHOS) complex I, III, IV, and V [58].”
BackgroundFission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 1×
“The irreversibly defective mitochondria need to be cleared in a timely manner, and mitochondrial fission has been shown to participate in the elimination of damaged mitochondria by autophagy [57].”
BackgroundER Tubules Mark Sites of Mitochondrial Division
Friedman, J. R., Lackner, L. L., West, M., DiBenedetto, J. R., Nunnari, J., & Voeltz, G. K. (2011) · Science · doi:10.1126/science.1207385 · Cited by 2,072 · cited 2×
“Most recent studies imply that endoplasmic reticulum (ER), together with actin filaments, plays a critical role in the establishment of constriction sites before mitochondrial Drp1 recruitment [25,26].”
BackgroundMitochondria: More Than Just a Powerhouse
McBride, H. M., Neuspiel, M., & Wasiak, S. (2006) · Current Biology · doi:10.1016/j.cub.2006.06.054 · Cited by 1,985
Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian Cells
Smirnova, E., Griparic, L., Shurland, D.-L., & van der Bliek, A. M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2245 · Cited by 1,933 · cited 1×
“The key regulator in the mitochondria fission process is dynamin-related protein1 (Drp1 or DLP1), a large GTPase mainly localized in the cytosol [19].”
BackgroundDrosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
Cited by
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 581
Ježek, J., Cooper, K., & Strich, R. (2018) · Antioxidants · doi:10.3390/antiox7010013 · Cited by 514
Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View
Cenini, G., Lloret, A., & Cascella, R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2105607 · Cited by 499
“Moreover, changes in the levels of Fis1, Mfn1, OPA1, and Drp1 preceded motoneuron loss and symptom onset in SOD1 mutant [242].”
BackgroundAgeing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Cellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
“Evidence for the relation between oxidative stress and cellular senescence in AD comes from studies in mouse models of AD in which the animals were subjected to chronic oxidative stress (SIPS) and found cellular changes identical to those found in other types of senescence: i.e., an increase in SA-β-gal expression, ce…”
BackgroundInfluentialHydrogen sulfide signaling in mitochondria and disease
Murphy, B., Bhattacharya, R., & Mukherjee, P. (2019) · The FASEB Journal · doi:10.1096/fj.201901304r · Cited by 279
“Abnormal mitochondrial morphology has been linked to several neurodegenerative disease states, such as PD, butH2S signaling and therapy in this context have yet to be examined (250, 251).”
BackgroundFunctions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology
Kumar, S., & Lombard, D. B. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1458071 · Cited by 269
“Role of SIRT5 in the pathogenesis of neurodegenerative disorders Mitochondrial dysfunction and oxidative stress have been implicated in the pathogenesis of many neurodegenerative diseases, such as Parkinson’s disease (PD) (Gao et al. 2017).”
BackgroundThe Association of Tau With Mitochondrial Dysfunction in Alzheimer’s Disease
Cheng, Y., & Bai, F. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00163 · Cited by 239
“It is reported that mitochondrial dysfunction and abnormal morphology are prominent features of AD (Wang et al., 2014b; Gao et al., 2017; Guo et al., 2017).”
BackgroundJamwal, S., Blackburn, J. K., & Elsworth, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107705 · Cited by 236
“, 2019; Tarasov, Griffiths, & Rutter, 2012) whereas under pathological stress, mitochondria generate excessive reactive oxygen species (ROS) and receive a massive influx of calcium, initiating the formation of the mitochondrial permeability transition pore complex which can lead to cell death (Gao et al., 2017; Taraso…”
BackgroundPathomechanisms of TDP‐43 in neurodegeneration
Gao, J., Wang, L., Huntley, M. L., Perry, G., & Wang, X. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14327 · Cited by 228
“Mitochondria have been increasingly indicated as targets of Ab and tau (Gao et al. 2017), therefore implicating the possible convergence of Ab, tau, and TDP-43 pathogenic pathways at the point of impairing mitochondrial function.”
BackgroundSelf-citationMitochondrial dynamics and their potential as a therapeutic target
Whitley, B. N., Engelhart, E. A., & Hoppins, S. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.06.002 · Cited by 226
Connolly, N. M. C., Theurey, P., Adam-Vizi, V., Bazan, N. G., Bernardi, P., Bolaños, J. P., Culmsee, C., Dawson, V. L., Deshmukh, M., Duchen, M. R., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0020-4 · Cited by 204
“Several of these genes (PSEN1/2; SNCA, DJ-1, LRRK2, Parkin, PINK1; MAPT; Htt; SOD1, FUS, TARDP, and CHCHD10) encode proteins that regulate mitochondrial homeostasis and function to varying degrees [3, 5, 18, 19].”
BackgroundThe biosynthesis, signaling, and neurological functions of bile acids
Kiriyama, Y., & Nochi, H. (2019) · Biomolecules · doi:10.3390/biom9060232 · Cited by 204
Kabir, M. T., Rahman, M. H., Shah, M., Jamiruddin, M. R., Basak, D., Al-Harrasi, A., Bhatia, S., Ashraf, G. M., Najda, A., El-kott, A. F., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112610 · Cited by 181
Yang, X., Xue, P., Chen, H., Yuan, M., Kang, Y., Duscher, D., Machens, H., & Chen, Z. (2020) · Theranostics · doi:10.7150/thno.40857 · Cited by 165
“As such, loss or dysfunction of the mitochondrial fusion or division machines are broadly confirmed in neurodegenerative diseases, heart failure, diabetes and cancer [12-15].”
BackgroundMitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies
Vastegani, S. M., Nasrolahi, A., Ghaderi, S., Belali, R., Rashno, M., Farzaneh, M., & Khoshnam, S. E. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03904-0 · Cited by 159
“Most of the genetic, mitochondria-related PD proteins are involved in mitochondrial dynamics and the trafficking process [221].”
BackgroundMitochondrial dysfunction: A fatal blow in depression
Song, Y., Cao, H., Zuo, C., Gu, Z., Huang, Y., Miao, J., Fu, Y., Guo, Y., Jiang, Y., & Wang, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115652 · Cited by 156
Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Prasuhn, J., Davis, R. L., & Kumar, K. R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.615461 · Cited by 141
“The majority of genetic PD proteins locating to mitochondria and mitochondriaER contact sites are associated with processes influencing or influenced by mitochondrial dynamics and trafficking (Gao et al., 2017; Cutillo et al., 2020).”
BackgroundTabassum, R., & Jeong, N. Y. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.36516 · Cited by 138
Neuronal Mitochondria Modulation of LPS-Induced Neuroinflammation
Harland, M., Torres, S., Liu, J., & Wang, X. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2324-19.2020 · Cited by 127
“…pathological features, both mitochondrial dysfunction and neuroinflammation are closely associated with pathological hallmarks (Heneka et al., 2015; Gao et al., 2017), and have been implicated as interdependent pathological lesions in neurodegenerative diseases (Wilkins and Swerdlow, 2016).”
BackgroundSelf-citationMitochondrial dynamics, a key executioner in neurodegenerative diseases
Panchal, K., & Tiwari, A. K. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.11.002 · Cited by 136
The role of amyloid oligomers in neurodegenerative pathologies
Wells, C., Brennan, S. E., Keon, M., & Ooi, L. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.03.113 · Cited by 137
Grel, H., Woźnica, D., Ratajczak, K., Kalwarczyk, E., Anchimowicz, J., Świtlik, W. Z., Olejnik, P., Zielonka, P., Stobiecka, M., & Jakieła, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713033 · Cited by 147
Ihenacho, U. K., Nolden, K. A., Harwig, M. C., Widlansky, M. E., & Hill, R. B. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.660095 · Cited by 128
ROS as Regulators of Mitochondrial Dynamics in Neurons
Cid‐Castro, C., Hernández-Espinosa, D. R., & Morán, J. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0584-7 · Cited by 122
Bathini, M., Raghushaker, C. R., & Mahato, K. K. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-01016-9 · Cited by 122
Infectious disease-associated encephalopathies
Barbosa‐Silva, M. C., Lima, M. N., Battaglini, D., Robba, C., Pelosi, P. P., Rocco, P. R. M., & Maron‐Gutierrez, T. (2021) · Critical Care · doi:10.1186/s13054-021-03659-6 · Cited by 130
Current progress of mitochondrial transplantation that promotes neuronal regeneration
Chang, C.-Y., Liang, M.-Z., & Chen, L. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0158-8 · Cited by 110
“The toxicity of mutant PD-associated proteins, including PINK1, Parkin, LRRK2, protein deglycase DJ-1,vacuolar protein sorting-associated protein 35, and α-synuclein, accounts for mitochondrial fission, impaired mitophagy, and neuronal death in the PD genetic models [15, 31].”
BackgroundLee, J. M., Hwang, J. W., Kim, M. J., Jung, Y., Kim, K., Ahn, E. H., Min, K., & Choi, Y. (2021) · Antioxidants · doi:10.3390/antiox10050696 · Cited by 102
Jadiya, P., Garbincius, J. F., & Elrod, J. W. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01224-4 · Cited by 99
The Retromer Complex and Sorting Nexins in Neurodegenerative Diseases
Zhang, H., Huang, T., Hong, Y., Yang, W., Zhang, X., Luo, H., Xu, H., & Wang, X. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00079 · Cited by 88
“For example, aberrations in mitochondrial dynamics and mitophagy have been observed in PD pathogenesis (Bose and Beal, 2016; Gao et al., 2017).”
BackgroundSelf-citationRocha, S., Freitas, A., Guimarães, S., Vitorino, R. M. P., Aroso, M., & Gómez-Lázaro, M. (2017) · Antioxidants · doi:10.3390/antiox7010001 · Cited by 94
Pascual-Ahuir, A., Manzanares-Estreder, S., & Proft, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9860841 · Cited by 81
Wu, W., Zhao, D., Shah, S. Z. A., Zhang, X., Lai, M., Yang, D., Wu, X., Guan, Z., Li, J., Zhao, H., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1953-y · Cited by 82
Aishwarya, R., Alam, S., Abdullah, C. S., Morshed, M., Nitu, S. S., Panchatcharam, M., Miriyala, S., Kevil, C. G., & Bhuiyan, M. S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101660 · Cited by 88
“This protein translocates to mitochondrial fission sites on the outer mitochondrial membrane where it interacts with multiple adaptor proteins, including mitochondrial fission 1 (Fis1), mitochondrial dynamics proteins of 49 and 51 kDa (MiD49/51), and mitochondrial fission factor (Mff) [1,2].”
BackgroundShaito, A. A., Al‐Mansoob, M., Ahmad, S. M. S., Haider, M. Z., Eid, A. H., Posadino, A. M., Pintus, G., & Giordo, R. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666221012122855 · Cited by 96
Zhou, Y., Tang, J., Lan, J., Zhang, Y., Wang, H., Chen, Q., Kang, Y., Sun, Y., Feng, X., Wu, L., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.07.019 · Cited by 80
Qi, Z., Huang, Z., Xie, F., & Chen, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27866 · Cited by 87
“…ALS are Riluzole and Edaravone, which are the glutamate release inhibitor and free radical scavenger, so the development and application of new drugs (Table 2) is imminent (Altanbyek et al., 2016; Chaturvedi & Flint Beal, 2013; Gao et al., 2017; Joshi, Saw, Vogel et al., 2018; Liu et al., 2013).”
BackgroundSelf-citationLimanaqi, F., Biagioni, F., Mastroiacovo, F., Polzella, M., Lazzeri, G., & Fornai, F. (2020) · Antioxidants · doi:10.3390/antiox9101022 · Cited by 85
Yadav, E., Yadav, P. S., Khan, M. M. U., Singh, H., & Verma, A. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.922232 · Cited by 91
“regulated by mitochondrial dynamics and they are highly prone to anymodification inmitochondrial dynamics (Gao et al., 2017).”
BackgroundCarelli, S., Rey, F., Ottolenghi, S., Zuccotti, G., & Samaja, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.322430 · Cited by 82
“Here, we will provide a brief overview of recent advances in these dysfunctions, which have been extensively addressed in multiple studies (Burté et al., 2015; Gao et al., 2017; Wang et al., 2019; Kodavati et al., 2020; Monzio Compagnoni et al., 2020).”
InfluentialFunctions of Astrocytes under Normal Conditions and after a Brain Disease
Vallés, S. L., Singh, S. K., Campos-Campos, J., Colmena, C., Campo-Palacio, I., Alvarez-Gamez, K., Caballero, Ó., & Jorda, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098434 · Cited by 86
Mitochondrial division, fusion and degradation
Murata, D., Arai, K., Iijima, M., & Sesaki, H. (2019) · The Journal of Biochemistry · doi:10.1093/jb/mvz106 · Cited by 77
“Mitofusin 2 is mutated in Charcot-Marie-Tooth type 2A and Opa1 is mutated, as its name suggests, in dominant optic atrophy (21, 22).”
BackgroundEmerging Roles of SIRT5 in Metabolism, Cancer, and SARS-CoV-2 Infection
Fabbrizi, E., Fiorentino, F., Carafa, V., Altucci, L., Mai, A., & Rotili, D. (2023) · Cells · doi:10.3390/cells12060852 · Cited by 81
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5
Fiorentino, F., Castiello, C., Mai, A., & Rotili, D. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00687 · Cited by 72
Roe, A. J., & Qi, X. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.114 · Cited by 73
“Excessive mitochondrial fission causes mitochondrial fragmentation, which leads to permeabilization of the outer mitochondrial membrane, ATP depletion, increase of ROS, and release of apoptotic factors [5,7].”
BackgroundDeep Analysis of Mitochondria and Cell Health Using Machine Learning
Zahedi, A., On, V., Phandthong, R., Chaili, A., Remark, G., Bhanu, B., & Talbot, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-34455-y · Cited by 80
Pantiya, P., Thonusin, C., Chattipakorn, N., & Chattipakorn, S. C. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.08.003 · Cited by 70
Liang, J., Wang, C., Zhang, H., Huang, J., Xie, J., & Chen, N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.755665 · Cited by 75
Mitochondria and the Brain: Bioenergetics and Beyond
Belenguer, P., Duarte, J. M. N., Schuck, P. F., & Ferreira, G. C. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00061-7 · Cited by 73
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease
Canepa, E., & Fossati, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.573324 · Cited by 67
Bhatti, G. K., Gupta, A., Pahwa, P., Khullar, N., Singh, S., Navik, U., Kumar, S., Mastana, S. S., Reddy, A. P., Reddy, P. H., et al. (2022) · Biomedical Journal · doi:10.1016/j.bj.2022.05.002 · Cited by 78
“radical scavenging, regulating the basic metabolism [3].”
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 83
“Astrocytes are essential contributors to the development and spread of the illness and, depending on various variables can have both advantageous and unfavorable effects (Gao et al., 2017; Chun and Lee, 2018).”
BackgroundThe Multifaceted Roles of Zinc in Neuronal Mitochondrial Dysfunction
Liu, H. Y., Gale, J. R., Reynolds, I. J., Weiss, J. H., & Aizenman, E. (2021) · Biomedicines · doi:10.3390/biomedicines9050489 · Cited by 75
“Furthermore, whether excess zinc interferes with this mitochondrial surveillance mechanism has not yet been demonstrated in neurons, although it is an intriguing topic of future study due to the extent that DRP1 activation and mitophagy have been implicated in the pathology of various neurodegenerative diseases [230],”
BackgroundInfluentialShin, S. J., Nam, Y., Park, Y. H., Kim, M., Lee, E., Jeon, S. G., Bae, B.-S., Seo, J., Shim, S., Kim, J.-S., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.454 · Cited by 62
Marón, F. J. M., Camargo, A. B., & Manucha, W. A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117513 · Cited by 69
Lu, Y., Chen, L., Ye, J., Chen, C., Zhou, Y., Li, K., Zhang, Z., & Peng, M. (2020) · Aging · doi:10.18632/aging.102659 · Cited by 69
“com 855 AGING Drp1 and Mfn2 are two key GTPase proteins responsible for maintaining mitochondrial fission and fusion dynamics [15, 33].”
BackgroundRisks of cognitive detriments after low dose heavy ion and proton exposures
Cucinotta, F. A., & Cacao, E. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1623427 · Cited by 58
“Disturbance of mitochondrial dynamic regulators (such as Drp1, pDrp1, SNO-Drp1, Mfn1/2, Fis1 and Miro 1) results in abnormalities in fusion, fission, trafficking and proper transport and localization of mitochondria in neurites and synapses that eventually leads to degeneration and neuronal death (Gao et al. 2017).”
BackgroundLoss of the mitochondrial i‐AAA protease YME1L leads to ocular dysfunction and spinal axonopathy
Sprenger, H., Wani, G. A., Hesseling, A., König, T., Patrón, M., MacVicar, T., Ahola, S., Wai, T., Barth, E., Rugarli, E. I., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809288 · Cited by 62
“Similarly, depletion of axonal mitochondria in midbrain dopamine neurons was observed in the absence of DRP1 and mitochondrial fission (Berthet et al, 2014; Sheng, 2014; Gao et al, 2017).”
BackgroundThe existence and function of mitochondrial component in extracellular vesicles
Liu, D., Dong, Z., Wang, J., Tao, Y., Sun, X., & Yao, X. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.08.005 · Cited by 62
Babazadeh, A., Vahed, F. M., Liu, Q., Siddiqui, S. A., Kharazmi, M. S., & Jafari, S. M. (2023) · ACS Omega · doi:10.1021/acsomega.2c06098 · Cited by 67
Mitochondrial dynamics, mitophagy and biogenesis in neonatal hypoxic‐ischaemic brain injury
Thornton, C., Jones, A., Nair, S., Aabdien, A., Mallard, C. E., & Hagberg, H. (2017) · FEBS Letters · doi:10.1002/1873-3468.12943 · Cited by 62
Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities
Soares, P., Silva, C., Chavarria, D., Silva, F. S. G., Oliveira, P. J., & Borges, F. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101790 · Cited by 61
Eshraghi, R. S., Deth, R. C., Mittal, R., Aranke, M., Kay, S.-I. S., Moshiree, B., & Eshraghi, A. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00256 · Cited by 60
Huo, X., Reyes, T. M., Heijnen, C. J., & Kavelaars, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-35919-x · Cited by 55
Dosis Facit Sanitatem—Concentration-Dependent Effects of Resveratrol on Mitochondria
Madreiter‐Sokolowski, C. T., Sokolowski, A., & Graier, W. F. (2017) · Nutrients · doi:10.3390/nu9101117 · Cited by 55
Tyumentsev, M. A., Stefanova, N. A., Muraleva, N. A., Rumyantseva, Y. V., Kiseleva, E., Vavilin, V. A., & Kolosova, N. G. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180065 · Cited by 50
“…or possibly even initiate pathological molecular cascades of sporadic AD; this evidence supports the hypothesis of a primary mitochondrial cascade,whichmeansthatmitochondrialdysfunction existsindependentlyofamyloid-(cid:2) (A (cid:2) ), and potentially is upstream of A (cid:2) deposition [7].”
Miyai, T., Vasanth, S., Melangath, G., Deshpande, N., Kumar, V., Benischke, A., Chen, Y., Price, M. O., Price, F. W., & Jurkunas, U. V. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.06.012 · Cited by 56
An update on cell-penetrating peptides with intracellular organelle targeting
Cerrato, C. P., & Langel, Ü. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2034784 · Cited by 50
Role of Mitofusins and Mitophagy in Life or Death Decisions
Joaquim, M., & Escobar‐Henriques, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.572182 · Cited by 52
Zhang, X., Huang, W., 邵千航, Yang, Y., Xu, Z., Chen, J., Zhang, X., & Ge, X. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.02.009 · Cited by 52
Zafeer, M. F., Firdaus, F., Anis, E., & Hossain, M. S. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.04.006 · Cited by 50
The relevance of mitochondrial morphology for human disease
Navaratnarajah, T., Anand, R., Reichert, A. S., & Distelmaier, F. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105951 · Cited by 54
Panchal, K., & Tiwari, A. K. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.10.005 · Cited by 50
Retrotransposons as a Source of DNA Damage in Neurodegeneration
Pezé-Heidsieck, E., Bonnifet, T., Znaidi, R., Ravel‐Godreuil, C., Massiani-Beaudoin, O., Joshi, R. L., & Fuchs, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.786897 · Cited by 59
“…and perspectives (Baker and Petersen, 2018) Mitochondrial dysfunction Abnormalities of mitochondrial dynamics in neurodegenerative diseases (Gao et al., 2017) Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure (Wang et al., 2019) Mitochondrial…”
BackgroundMarioli, C., Magliocca, V., Petrini, S., Niceforo, A., Borghi, R., Petrillo, S., Rosa, P. L., Colasuonno, F., Persichini, T., Piemonte, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197402 · Cited by 49
Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases
Shi, W., Tan, C., Liu, C., & Chen, D. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0056 · Cited by 53
ALS-associated mutation SOD1G93A leads to abnormal mitochondrial dynamics in osteocytes
Wang, H., Yi, J., Li, X., Xiao, Y., Dhakal, K. R., & Zhou, J. (2017) · Bone · doi:10.1016/j.bone.2017.10.010 · Cited by 43
Understanding Miro GTPases: Implications in the Treatment of Neurodegenerative Disorders
Kay, L., Pienaar, I. S., Cooray, R., Black, G. W., & Soundararajan, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0927-x · Cited by 45
“Mitochondrial fission, fusion, and transport play important roles in healthymitochondrial network [1, 2, 64].”
BackgroundMuddapu, V. R., Mandali, A., Chakravarthy, S. V., & Ramaswamy, S. (2019) · Frontiers in Neural Circuits · doi:10.3389/fncir.2019.00011 · Cited by 48
“Similar ideas have been proffered to account for other forms of neurodegeneration like, for example, Huntington’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis also (Beal et al., 1993; Johri and Beal, 2012; Gao et al., 2017).”
BackgroundJiang, X., Jin, T., Zhang, H., Miao, J., Zhao, X., Su, Y., & Zhang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4578462 · Cited by 43
“The kinetic defects within mitochondria usually become increasingly prominent during neurodegeneration, especially in the pathogenesis of PD [66, 67].”
Zhang, C., Wang, J., Zhu, J., Chen, Y., & Han, X. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134702 · Cited by 50
Mechanisms and repair strategies for white matter degeneration in CNS injury and diseases
Shahsavani, N., Kataria, H., & Karimi‐Abdolrezaee, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166117 · Cited by 45
Löffler, M., Carrey, E. A., & Knecht, W. (2020) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2020.1723625 · Cited by 43
Cystathionine β‐synthase regulates mitochondrial morphogenesis in ovarian cancer
Chakraborty, P. K., Murphy, B., Mustafi, S. B., Dey, A., Xiong, X., Rao, G., Naz, S., Zhang, M., Yang, D., Dhanasekaran, D. N., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201701095r · Cited by 42
ALS lymphoblastoid cell lines as a considerable model to understand disease mechanisms
Pansarasa, O., Bordoni, M., Dufruca, L., Diamanti, L., Sproviero, D., Trotti, R., Bernuzzi, S., Salvia, S. L., Gagliardi, S., Ceroni, M., et al. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031625 · Cited by 48
“These two processes are highly coordinated and strictly controlled by specific proteins: dynamin-related protein1 (Drp1) and fission 1 (Fis1) for the fission process, and mitofusin 1/2 (MFN1/2) and optic atrophy protein 1 (OPA1) for the fusion process (Gao et al., 2017).”
Chimeh, U., Zimmerman, M. A., Gilyazova, N., & Li, P. A. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.24702 · Cited by 41
Xie, W., Koppula, S., Kale, M. B., Ali, L. S., Wankhede, N. L., Umare, M. D., Upaganlawar, A. B., Abdeen, A., Ebrahim, E., El‐Sherbiny, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1469053 · Cited by 39
Involvement of mitophagy in cisplatin-induced cell death regulation
Abdrakhmanov, A., Kulikov, A. V., Luchkina, E. A., Zhivotovsky, B., & Gogvadze, V. G. (2018) · Biological Chemistry · doi:10.1515/hsz-2018-0210 · Cited by 38
Neuroglobin and mitochondria: The impact on neurodegenerative diseases
Fiocchetti, M., Cracco, P., Montalesi, E., Fernandez, V. S., Stuart, J. A., & Marino, M. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108823 · Cited by 39
Bakare, A. B., Daniel, J., Stabach, J., Rojas, A., Bell, A., Henry, B., & Iyer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126263 · Cited by 39
A role for the GDAP1 gene in the molecular pathogenesis of Charcot-Marie-Tooth disease
Rzepnikowska, W., & Kochański, A. (2018) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2018-002 · Cited by 34
Madhivanan, K., Greiner, E. R., Alves‐Ferreira, M., Soriano‐Castell, D., Rouzbeh, N., Aguirre, C., Paulsson, J. F., Chapman, J., Jiang, X., Ooi, F. K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801117115 · Cited by 40
Mitochondrial DNA and Neurodegeneration: Any Role for Dietary Antioxidants?
Bordoni, L., & Gabbianelli, R. (2020) · Antioxidants · doi:10.3390/antiox9080764 · Cited by 35
de Araujo, B. P. R., Silva, L., Torresi, J. L. D. B., Siena, A., Valério, B. C. O., Brito, M. D., & Rosenstock, T. R. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02059-1 · Cited by 33
Mangrulkar, S. V., Wankhede, N. L., Kale, M. B., Upaganlawar, A. B., Taksande, B. G., Umekar, M. J., Anwer, M. K., Dailah, H. G., Mohan, S., & Behl, T. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00647-2 · Cited by 37
“3) (Chen et al. 2003; Gao et al. 2017).”
BackgroundKim, H., Perentis, R. J., Caldwell, G. A., & Caldwell, K. A. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0619-5 · Cited by 37
Boosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 37
“characteristic of numerous neurodegenerative diseases (Gao et al., 2017).”
Jiang, L., & Ngo, S. T. (2022) · Metabolites · doi:10.3390/metabo12080709 · Cited by 39
Alcohol consumption during adolescence alters the hippocampal response to traumatic brain injury
Mira, R. G., Lira, M., Quintanilla, R. A., & Cerpa, W. F. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.160 · Cited by 34
Metadata
- Authors
- Gao, J., Wang, L., Liu, J., Xie, F., Su, B., & Wang, X.
- Affiliations
- Case Western Reserve University (US)
- Shandong University (CN)
- Corresponding author
- Wang, Xinglong
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2017-04-05
- Volume
- 6
- Issue
- 2
- Pages
- 25
- ISSN
- 2076-3921 (ISSN-L)
- PMC
- PMC5488005
- OpenAlex
- W2604387140
- Cited by
- 250
- References
- 178
- Citations by year
- 2026: 11 · 2025: 27 · 2024: 28 · 2023: 27 · 2022: 27 · 2021: 34 · 2020: 31 · 2019: 28 · 2018: 30 · 2017: 7
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antioxidants (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Alzheimer's Association (AARG-17-499682)
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS097679)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- mitochondrial dynamics, neurodegenerative diseases, mitochondrial fusion, mitochondrial fission, mitochondrial transport, Drp1, OPA1, mitofusins, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, mitochondrial dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.